CSF1 (Colony stimulating factor 1)

News alerts, weekly reports and conference planners

Entrez ID:

CSF1 expression	Renal Cell Carcinoma	CSF1 expression	Renal Cell Carcinoma	lenvatinib Sensitive: C3 – Early Trials lenvatinib Sensitive : C3	lenvatinib Sensitive: C3 – Early Trials lenvatinib Sensitive : C3
CSF1 underexpression	Squamous Cell Carcinoma of Head and Neck	CSF1 underexpression	Squamous Cell Carcinoma of Head and Neck	ABBV-181 Sensitive: C3 – Early Trials ABBV-181 Sensitive : C3	ABBV-181 Sensitive: C3 – Early Trials ABBV-181 Sensitive : C3
CSF1 underexpression	Non Small Cell Lung Cancer	CSF1 underexpression	Non Small Cell Lung Cancer	ABBV-181 Sensitive: C3 – Early Trials ABBV-181 Sensitive : C3	ABBV-181 Sensitive: C3 – Early Trials ABBV-181 Sensitive : C3
CSF1 elevation	Non Small Cell Lung Cancer	CSF1 elevation	Non Small Cell Lung Cancer	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3
COL6A3-CSF1 fusion	Tenosynovial Giant Cell Tumor	COL6A3-CSF1 fusion	Tenosynovial Giant Cell Tumor	gefitinib + mitoxantrone Sensitive: C4 – Case Studies gefitinib + mitoxantrone Sensitive : C4	gefitinib + mitoxantrone Sensitive: C4 – Case Studies gefitinib + mitoxantrone Sensitive : C4

Associations(5)